PRIME: Prototype-Driven Multimodal Pretraining for Cancer Prognosis with Missing Modalities
arXiv cs.LG / 4/8/2026
💬 OpinionIdeas & Deep AnalysisModels & Research
Key Points
- PRIME introduces a missing-aware multimodal self-supervised pretraining framework for cancer prognosis that can learn from patient cohorts where histopathology, gene expression, and pathology report modalities are partially missing.
- The method aligns heterogeneous modality embeddings into a unified token space and uses a shared prototype memory bank to perform latent-space semantic imputation via patient-level consensus retrieval, avoiding reconstruction of raw signals.
- PRIME trains with two complementary objectives—inter-modality alignment and post-fusion consistency under structured missingness augmentation—to keep representations predictive across arbitrary modality subsets.
- Experiments on TCGA using label-free pretraining across 32 cancer types show PRIME achieves the best macro-average performance among compared approaches and improves robustness under test-time missingness for multiple survival and event prediction tasks.
- The approach is described as supporting parameter-efficient and label-efficient downstream adaptation, suggesting practical deployment in fragmented clinical data settings.
Related Articles

The enforcement gap: why finding issues was never the problem
Dev.to

Agentic AI vs Traditional Automation: Why They Require Different Approaches in Modern Enterprises
Dev.to

Agentic AI vs Traditional Automation: Why Modern Enterprises Must Treat Them Differently
Dev.to

Agentic AI vs Traditional Automation: Why Modern Enterprises Can’t Treat Them the Same
Dev.to

THE ATLAS SESSIONS
Dev.to